Atea Pharmaceuticals (AVIR) Receivables (2021 - 2022)
Atea Pharmaceuticals has reported Receivables over the past 2 years, most recently at $4.5 million for Q3 2022.
Atea Pharmaceuticals has reported Receivables over the past 2 years, most recently at $4.5 million for Q3 2022.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month